The groundbreaking success of Sildenafil undeniably reshaped the medication landscape, but betting in companies heavily reliant on generic versions presents a challenging picture. While early returns were impressive, https://pharma372205.fitnell.com/82958868/sildenafil-and-big-pharma-a-risky-investment